Quick Answer
Intellia Therapeutics, Inc. reported Common Stock Shares Outstanding of 116.32 million shares for the year ending 2025.
- Intellia Therapeutics, Inc. showed an increase of +14.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Intellia Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), Intellia Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 4,445.8%.
- Historical annual values: Fiscal year 2025: 116.32 million shares | Fiscal year 2024: 102.03 million shares | Fiscal year 2023: 93.00 million shares | Fiscal year 2022: 87.10 million shares | Fiscal year 2021: 74.49 million shares | Fiscal year 2020: 66.23 million shares | Fiscal year 2019: 50.20 million shares | Fiscal year 2018: 45.22 million shares | Fiscal year 2017: 42.38 million shares | Fiscal year 2016: 36.02 million shares | Fiscal year 2015: 2.56 million shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: